J&J Targets China, Russia to Grow Medical Device Business

Johnson & Johnson’s medical device division will emphasize China, Russia and other emerging countries as a strategy to increase growth. J&J is already the largest healthcare company in China. Its medical device revenues were up 18% in China during 2013 to $1.4 billion. But global medical device sales were flat in Q1 of 2014, which prompted the company to review its plans for growth of the division. More details.... Stock Symbol: (NYSE: JNJ) Share this with colleagues: // //